1 - 6 of
6 for companies in category
Biotechnology in
Canada:
Develops enabling nucleic acid-based technology applications, aimed at large biosensor/molecular diagnostics, therapeutics, and energy generation/management markets.
Cell's nano sized technology is a low density emulsion, named LDE, with particles similar to the structure of low-density lipoprotein (LDL) which acquires the apo E while in the plasma, thus becoming capable of targeting and binding to the specific receptors of LDL existing on the surface of cellular membranes.
Protiva's 'SNALP' (for stable nucleic acid-lipid particles) are specialized lipid nanoparticles that fully encapsulate and systemically deliver a variety of nucleic acid molecules such as siRNA, aptamers and plasmid DNA.
Photon activaten nano drug delivery systems.
Tekmira is an emerging leader in the advancement of therapeutic agents based upon Nobel Prize winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi).
Zymeworks' core business focus is to develop a pipeline of enabling industrial enzymes for bio-processing and bio-product manufacturing. Zymeworks' core competency is in molecular simulations.
[First Page] [Prev] Showing page 1 of 1 pages [Next] [Last Page]
